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Abstract 
Background: Resveratrol is a plant natural product with many health‑protecting effects which makes it an attractive 
chemical both for academic studies and industrial purposes. However, the low quantities naturally produced by plants 
as well as the unsustainable procedures of extraction, purification and concentration have prompted many biotech‑
nological approaches to produce this chemical in large quantities from renewable sources. None of these approaches 
have considered a microbial coculture strategy to produce this compound. The aim of this study was to prove the 
functionality of a microbial coculture for the biosynthesis of resveratrol.
Results: In this work, we have successfully applied a coculture system strategy comprised of two populations of 
Escherichia coli strains, each with a partial and complementary section of the pathway leading to the biosynthesis of 
the stilbene resveratrol. The first strain is a pheA knockout mutant previously engineered to excrete p‑coumaric acid 
into the medium through the overexpression of genes encoding a tyrosine ammonia lyase from Rhodothorula glutinis, 
a feedback resistant 3‑deoxy‑D‑arabino‑heptulosonate 7‑phosphate synthase and a transketolase. The second strain 
in the coculture was engineered to express the second part of the resveratrol biosynthetic pathway through the intro‑
duction of synthetic genes encoding the 4‑coumaroyl‑CoA ligase from Streptomyces coelicolor A2 and the stilbene 
synthase either from the peanut Arachis hypogaea or the grapevine Vitis vinifera, the latter synthesized employing a 
gene harmonization strategy and showing better resveratrol production performance. Batch cultures were performed 
in mineral medium with glycerol as the sole carbon source, where a final titer of 22.6 mg/L of resveratrol was pro‑
duced in 30 h.
Conclusions: To our knowledge, this is the first time that a coculture of bacterial strains is used for the biosynthesis of 
resveratrol from glycerol, having the potential for a greater improvement in the product yield and avoiding the use of 
precursors such as p‑coumaric acid, yeast extract or an expensive inhibitor such as cerulenin.
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Background
Stilbenes are natural products from the phenylpropa-
noid family displaying extensive diversity of chemical 
structures and biological activities. The stilbene resvera-
trol can be found in red wine, and together with other 
phenolic compounds, it has been suggested to reduce 
the risk of coronary heart disease [1]. Even though more 
studies are needed to verify the cardioprotective effects 
of resveratrol in vivo, some studies have shown that res-
veratrol has potent antioxidant properties and inhibits 
lipid peroxidation, hence, protecting LDL molecules and 
contributing to prevent atherosclerosis [2]. Antitumor, 
neuroprotective, hypoglycemic and antimicrobial are 
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The first step in the biosynthesis of resveratrol is the 
transformation of l-phenylalanine or l-tyrosine into 
p-coumaric acid, which can proceed in two possible 
routes (Fig. 1); The first one is through the reactions cat-
alyzed by l-phenylalanine ammonia lyase (PAL) followed 
by the action of the cinnamate 4-hydroxylase (C4H); and 
the second one is through the sole action of the enzyme 
l-tyrosine ammonia lyase (TAL). C4H is a cytochrome 
P450 enzyme that requires the co-expression of a mem-
brane-bound cytochrome P450 reductase for its full 
functionality. The second step in resveratrol synthesis 
consists in the activation of p-coumaric acid through its 
esterification with one molecule of coenzyme A (CoA), 
which is performed by the enzyme 4-coumaroyl-CoA 
ligase (4CL), yielding p-coumaroyl-CoA. This is the 
starter molecule required by the last enzyme, stilbene 
synthase (STS), which catalyzes the condensation of 
one molecule of p-coumaroyl-CoA and three units of 
malonyl-CoA through a series iterative decarboxylating 
reactions that finish with the cyclization of a tetraketide 
intermediate, resulting in one molecule of trans-resver-
artrol. So far, many STS genes have been described from 
plants such as Vitis vinifera, Arachis hypogea, Fallopia 
japonica (syn. Polygonum cuspidatum), Rheum tatari-
cum, Parthenocissus henryana, Pinus, Sorghum, Petrose-
linum crispum and more, extending the repertoire of 
Fig. 1 Map of the trans‑resveratrol biosynthetic pathway. TAL, tyrosine ammonia lyase, PAL phenylalanine ammonia lyase, C4H cinnamate 4‑hydrox‑
ylase, 4CL 4‑coumaroyl‑CoA ligase, STS stilbene synthase, ACC acetyl‑CoA carboxylase
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enzymes that can be used for metabolic engineering of 
heterologous hosts.
Several strategies have been applied for the microbial 
production of resveratrol in Escherichia coli. An essential 
modification involves the heterologous expression of the 
genes coding for 4CL and STS enzymes. Strains express-
ing these genes have the capacity of converting supple-
mented p-coumaric acid into resveratrol [8]. Also, if a 
gene encoding for a TAL activity is expressed, then the 
strain is able to use supplemented l-tyrosine as a precur-
sor for resveratrol [9]. The amino acid l-phenylalanine 
could also be employed as a precursor, however, since the 
required expression of the P450 reductase is deficient in 
E. coli; this approach has not been successful [10]. Other 
additional modifications have been used to increase the 
availability of the precursor malonyl-CoA, such as the 
introduction of the genes matB and matC from Rhizo-
bium leguminosarum bv. trifolii which encode a malo-
nyl-CoA synthetase and a malonate transporter protein, 
respectively. These activities can increase the concentra-
tion of malonyl-CoA when cells are cultured in medium 
supplemented with malonate [9, 11, 12]. An alternative 
approach to increase malonyl-CoA involves the utiliza-
tion of cerulenin. This compound is an inhibitor of the 
fabB and fabF gene products which consume malonyl-
CoA for lipids biosynthesis. Although cerulenin addi-
tion has a clear positive effect on resveratrol production 
[13], the high cost of the inhibitor makes this strategy 
impractical. These and other strategies have been applied 
for optimization of E. coli strains and for improving the 
culture conditions, yielding resveratrol titers from 3.6 to 
2340 mg/L (Table 1).
In contrast to the rather artificial conditions used in 
industrial production processes, microbial species usu-
ally exist in Nature as part of a consortium. The members 
of a consortium contribute with specialized metabolic 
functions that help in surviving adverse and chang-
ing conditions. In biotechnological processes, consortia 
have been employed traditionally in bioremediation and 
water treatment applications. However, until recently, 
the simultaneous culture of two distinct metabolically 
engineered strains (coculture) was not used for the pro-
duction of useful compounds. This approach can reduce 
the metabolic burden of each strain and allow for paral-
lel optimization of the engineered pathway in a modular 
fashion. Distribution of a biochemical pathway into two 
strains also has the advantage of compartmentalization, 
preventing potential inhibiting metabolic intermediates 
from acting upon susceptible enzymes [14, 15]. Success-
ful coculture strategies have been reported for cis,cis-
muconic acid production in engineered E. coli strains 
[16, 17]. In these reports an improvement in production 
capacity of the coculture when compared to monoculture 
processes has been demonstrated [16, 17]. In another 
example, a coculture approach was employed to optimize 
flavan-3-ols production from phenylpropanoic acid pre-
cursors [18]. The six-step biosynthetic pathway leading to 
(+)-afzelechin and (+)-catechin was divided among two 
E. coli strains and strain optimization was complemented 
with computer-assisted process optimization considering 
Table 1 Comparison of reports on resveratrol production using E. coli strains
Microorganism Precursor Time of culture/media Genes introduced Genes origin Production 
(mg/L)
Reference
E. coli p‑coumaric acid  24 h, 2 × YT 4CL, STS N. tabacum (4CL), V. vinifera 
(STS)
16 [29]
E. coli p‑coumaric acid 19 h, M9 + yeast 
extract + glycerol
4CL, STS A. thaliana (4CL), A. hypogaea 
(STS)
104.5 [8]
E. coli p‑coumaric acid 72 h, minimal MOPS 
medium + glucose
4CL, STS S. coelicolor (4CL), V. vinifera 
(STS)
3.6 [30]
E. coli p‑coumaric acid 60 h, M9 + yeast 
extract + glucose
4CL, STS Lithospermum erythrohizon 
(4CL), A. hypogaea (STS)
171 [31]
E. coli p‑coumaric acid 24 h, M9 + yeast 
extract + glycerol, 
cerulenin
4CL, STS A. thaliana (4CL), V. vinifera 
(STS)
2340 [13]
E. coli l‑tyrosine, 
malonate
48 h, minimal MOPS 
medium + glucose
TAL, 4CL, STS, MatB, 
MatC
R. glutinis (TAL), Petroselinum 
crispum (4CL), V. vinifera 
(STS), R. trifoli (matB, matC)
35 [9]
E. coli p‑coumaric acid 20 h, M9 + glycerol 4CL, STS S. coelicolor (4CL), V. vinifera 
(STS)
78.1 This work
E. coli/E.coli pheA‑ 
(Coculture)
20 h, M9 + glycerol + l‑
Phe
TAL, 4CL, STS R. glutinis (TAL), S. coelicolor 
(4CL), V. vinifera (STS)
22 This work
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variables such as carbon source, gene induction, temper-
ature and inoculation ratio. The final optimized system 
resulted in a 970-fold improvement in product titer over 
previous reports of monocultures [18].
For the case of resveratrol biosynthesis, the strategies 
to optimize the carbon flux towards the aromatic amino 
acids biosynthetic pathway could hinder optimization 
strategies to simultaneously increase the pool of malo-
nyl-CoA because of the divergent nature of these path-
ways. To overcome this issue, a coculture approach might 
represent a better choice, allowing for individual design 
and optimization of two strains; each one specialized to 
efficiently provide one of the precursors of the heterolo-
gous pathway, following the principle of an assembly line 
based on stages. Accordingly, the resveratrol biosynthetic 
pathway can be divided into two parts; on one hand, har-
nessing the metabolic machinery of one strain to synthe-
size p-coumaric acid and excrete it to the medium, and 
then a second engineered strain able to efficiently pro-
vide the acyl extender units of malonyl-CoA to the STS 
and finally yielding resveratrol. Furthermore, it has been 
suggested that TAL enzymes could be inhibited by cou-
maroyl-CoA [12]. Therefore, by splitting the pathway into 
two separate strains, this potential inhibition could be 
prevented, given the artificial compartmentalization of 
coumaroyl-CoA and TAL (Fig. 2). In this work, we show 
the feasibility of dividing the resveratrol biosynthetic 
pathway among two different E. coli strains to produce 
this compound in a coculture.
Results and discussion
Selection of 4CL and STS enzymes and characterization 
of resveratrol biosynthesis in minimal medium 
with supplementation of p‑coumaric acid
As an initial step to generate a bacterial platform for the 
biosynthesis of resveratrol, we first built a plasmid for 
expressing the genes coding for the last two enzymes 
required by the biosynthetic pathway: 4CL and STS. We 
chose to express the 4CL from Streptomyces coelicolor A2 
given its microbial origin and its high catalytic efficiency 
compared to other homologous enzymes [19]. In the case 
of STS, we decided to test the performance of enzymes 
from two distinct origins: A. hypogaea (AhSTS) and V. 
vinifera (VvSTS), since previous studies have shown that 
these proteins display better catalytic properties com-
pared to others [13]. The transformed resultant E. coli 
W3110 strains were named W-Ah and W-Vv, respectively. 
These strains were cultured in M9 minimal medium sup-
plemented with glucose or glycerol, and we added p-cou-
maric acid as a precursor for resveratrol, given that these 
strains do not express a TAL enzyme. In this experiment, 
we tested the expression and functionality of the plasmid-
encoded proteins in an environment non-limited for one 
of the two resveratrol precursors (p-coumaric acid).
Fig. 2 Schematic diagram of the coculture system proposed for the biosynthesis of resveratrol. Episomal expression of the correspondent genes is 
represented by thicker green arrows and bold names, whereas the red cross indicates inactivation of the corresponding gene in bold. G3P glyceralde‑
hyde‑3‑phosphate, PEP phosphoenolpyruvate, E4P erithrose 4‑phosphate, DHAP 3‑deoxy‑d‑arabino‑heptulosonate 7‑phosphate, PPh prephenate, 
PP phenylpyruvate, HPP hydroxyphenylpyruvate, L-PHE L‑phenylalanine, L-TYR L‑tyrosine, p-CA p‑coumaric acid, PYR pyruvate
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We set up shake flask cultures and induced the expres-
sion of the plasmid-encoded enzymes by adding 0.5 mM 
of IPTG when cells reached an O.D.600 of 0.8. The growth 
kinetic parameters are shown in Table  2. Our results 
showed that the use of glycerol as a carbon source causes 
a higher resveratrol production when compared to glu-
cose (Fig. 3; Table 3). When we compared the final res-
veratrol titers as a function of the carbon source, strain 
W-Vv showed an almost 16 % increase, while the strain 
W-Ah showed an even larger increase of about threefold 
when grown in glycerol compared to glucose (Table  3). 
The higher difference observed in the case of W-Ah com-
pared to W-Vv could be a consequence of the distinct 
catalytic properties of both enzymes (AhSTS and VvSTS) 
and their expression levels. Enzyme VvSTS is highly 
expressed and has around twice the turnover number 
when compared to the enzyme from A. hypogaea (Fig. 4) 
[13]. These two features could explain the observed 
results.
Clear differences in resveratrol production were also 
observed concerning the origin of the STS enzyme 
encoded in each plasmid vector. In shake-flask cultures 
grown in glycerol, strain W-Vv reached 2.8-fold higher 
resveratrol titers than strain W-Ah (Table 3). In glucose 
supplemented medium, the difference was even more 
evident, since resveratrol titers in strain W-Vv were about 
sevenfold higher than the strain W-Ah (Table 3).
We performed an SDS-PAGE stained with Coomas-
sie blue to determine the relative protein levels of the 
enzymes 4CL and STS at the end of the production 
cultures (Fig.  4). Lower levels of all the heterologous 
enzymes were observed in cultures grown on glucose 
compared to glycerol. The levels of 4CL displayed a 
slightly lower expression in glucose compared to glycerol. 
These results suggest that a physiological component of 
the expression apparatus might be sensitive to the nature 
of the carbon source, affecting the synthesis of these pro-
teins. However, the most evident difference regarding the 
protein levels of the heterologous enzymes was related 
to the origin of the expressed genes. We found that the 
levels of VsSTS were significantly higher than the levels 
of AhSTS (Fig. 4). Further studies are needed to establish 
whether the differences in the expression of these two 
enzymes is a consequence of dissimilarities in the stabil-
ity of the RNA transcript, the translation efficiency or the 
protein stability. These results agree well with the pro-
duction levels of resveratrol as described above (Table 3) 
and suggests that the higher expression of the heterolo-
gous proteins in cultures grown in glycerol and the higher 
expression of the STS from V. vinifera accounts for the 
higher resveratrol titers observed when using this carbon 
source. A possible explanation for this observation is that 
a higher enzyme activity due to the higher abundance of 
the stilbene synthase could help in driving the carbon 
flux from malonyl-CoA towards the synthesis of resvera-
trol. An alternative explanation arises from the analysis 
of acetate metabolism and its relation with acetyl-CoA. 
The inhibition of STS by acetyl-CoA has been studied by 
the group of Koffas et al. [13]. They reported an apparent 
competitive inhibition constant of about 460 μM, trig-
gered by acetyl-CoA against STS activity from V. vinifera 
[13]. However, they assumed that the intracellular levels 
of acetyl-CoA in E. coli cells were not as high to produce 
a significant inhibition of STS. Nevertheless, according 
to Takamura et  al., under aerobic and glucose growth 
conditions, the acetyl-CoA concentration in E. coli cells 
range from 20–600 μM [20]. Therefore, it is possible that 
the intracellular concentration of acetyl-CoA exerts a 
substantial inhibitory effect on the STS. In support for 
this hypothesis, we found an inverse relation between 
the titers of resveratrol and the amount of acetate accu-
mulated in the culture medium (Fig. 3, Tables 3 and 4). 
The higher content of acetate in glucose-grown cultures 
agrees with the previous observation that glucose-grown 
Table 2 Growth kinetic parameters for  monocultures 
in M9 mineral medium, 30 °C
GLC glucose, GLY glycerol
a Calculated from the exponential growth phase
Strain Sub‑
strate







GLC 0.25 ± 0.01 1.32 ± 0.02 0.32 ± 0.08 0.79 ± 0.20
W/
AhSTS
GLY 0.18 ± 0.01 1.11 ± 0.00 0.45 ± 0.25 0.48 ± 0.19
W/VvSTS GLC 0.29 ± 0.01 1.48 ± 0.03 0.48 ± 0.07 0.60 ± 0.06
W/VvSTS GLY 0.18 ± 0.00 1.16 ± 0.04 0.17 ± 0.02 1.12 ± 0.10
Fig. 3 Resveratrol titers and acetate production. Final titers of 
resveratrol and acetate after 30 h of culture in M9 mineral medium 
supplemented with glycerol or glucose and p‑coumaric acid. Vv, 
STS from V. vinifera; Ah, STS from A. hypogaea. Error bars represent 
standard deviation
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cells have higher intracellular acetyl-CoA levels than cells 
grown in glycerol, given that acetyl-CoA is a direct pre-
cursor of acetate [20]. However, other factors such as a 
different carbon flux distribution, the  loss of carbon in 
acetate formation and the potential toxic effect of this 
organic acid, could also contribute to the observed differ-
ences in resveratrol production when comparing cultures 
in glucose with respect to glycerol.
Additionally, as was suggested by Watts et  al. [8] the 
transport of phenylpropanoids into the cytoplasm of E. 
coli could be inhibited in cells growing in glucose due 
to the catabolic repression of the operons hca and mhp 
involved in the transport and catabolism of these com-
pounds. Therefore, cell cultures supplemented with glyc-
erol instead of glucose could help in the maintenance of 
a constant flux of p-coumaric acid into the cells, driving 
forward resveratrol biosynthesis.
Characterization of monocultures for the production 
of p‑coumaric acid and resveratrol
The following experiments were performed with a strain 
expressing the STS from V. vinifera since higher resvera-
trol titers were produced by the E. coli strain expressing 
the gene encoding this enzyme. Previously in our group, 
we reported an engineered strain for the production 
of p-coumaric acid [21]. This strain harbors a plasmid 
encoding the TAL enzyme from the yeast Rhodotho-
rula glutinis and another plasmid with the E. coli genes 
aroGfbr and tktA encoding a feedback-inhibition-resistant 
3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) 
synthase and a transketolase, respectively. Furthermore, 
to improve l-tyrosine accumulation, in this strain the 
pheA gene which encodes for a chorismate mutase/pre-
phenate dehydratase, was inactivated. The enzyme TAL 
from R. glutinis was selected since it showed a higher 
affinity towards l-tyrosine rather than l-phenylalanine 
[21]. This E. coli strain was named W(pheA-)Rg.
To characterize strains W(pheA-)Rg and W-Vv, we per-
formed shake-flask cultures individually with each strain 
in M9 mineral salts medium supplemented with glycerol 
as the sole carbon source. The results showed that both 
strains display similar specific growth rates (Fig.  5a, b) 
(Table 5). When compared to W(pheA-)Rg, strain W-Vv 
reached around a 20 % higher biomass, but the consump-
tion rate of glycerol appeared lower. The production of 
p-coumaric acid by strain [W(pheA−)Rg] reached 133 
uM (~22 mg/L) and resveratrol from W-Vv, upon addi-
tion of 3  mM of p-coumaric acid, reached  ~78.1  mg/L 
(Fig.  5b). These results are the highest resveratrol titers 
reported with an E. coli recombinant strain cultured in 
mineral medium without yeast extract supplementation. 
Table 3 Resveratrol production parameters for monocultures in M9 mineral medium, 30 °C
GLC glucose, GLY glycerol
Strain Substrate YR/S (mgP/gS) YP/X (mgp/gDCW) QP (mgp/L h) Resveratrol (mg/L)
W/AhSTS GLC 1.83 ± 0.26 7.78 ± 1.02 0.40 ± 0.06 8.04 ± 1.11
W/AhSTS GLY 11.75 ± 1.53 34.86 ± 5.48 1.42 ± 0.20 28.31 ± 3.93
W/VvSTS GLC 13.52 ± 0.34 55.16 ± 4.77 3.26 ± 0.39 65.28 ± 7.70
W/VvSTS GLY 39.44 ± 1.77 84.51 ± 2.92 3.71 ± 0.09 74.30 ± 1.84
Fig. 4 Effect of the carbon source and enzyme origin on the protein 
levels of 4CL and STS. 12 % SDS‑PAGE stained with Coomasie blue. 
4CL = 55.3 kDa; AhSTS = 42.8 kDa; VvSTS = 42.8 kDa
Table 4 Acetate production parameters for  monocultures 
in M9 mineral medium, 30 °C
GLC glucose, GLY glycerol
a Calculated from the exponential growth phase
Strain Sub‑
strate









GLC 0.13 ± 0.03 0.41 ± 0.02 0.10 ± 0.01 0.82 ± 0.03
W/
AhSTS
GLY 0.04 ± 0.02 0.10 ± 0.01 0.02 ± 0.00 0.45 ± 0.02
W/VvSTS GLC 0.15 ± 0.03 0.30 ± 0.02 0.09 ± 0.01 0.35 ± 0.03
W/VvSTS GLY 0.01 ± 0.01 0.05 ± 0.06 0.01 ± 0.01 0.19 ± 0.01
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Coculture in M9 mineral medium for the production 
of resveratrol from glycerol
To determine the feasibility of reconstituting a fully 
functional biosynthetic pathway to produce resveratrol, 
the strain with the capacity of transforming glycerol to 
p-coumaric acid (W(pheA-)Rg) and the strain able to 
convert it to resveratrol (W-Vv), were  both grown in a 
coculture in M9 mineral medium supplemented with 
glycerol as the sole carbon source. It is important to point 
out that neither p-coumaric acid nor yeast extract were 
supplemented to the culture medium.
Under coculture conditions, the growth rate was simi-
lar to that observed for single strain cultures (Fig.  6; 
Tables  5 and 6). Both strains were inoculated at a ratio 
of 1:1 (initial O.D.600 of 0.1), and the final biomass was 
1.78 g/L. Compared to monoculture results, p-coumaric 
acid accumulation was lower, which can be partially 
explained considering that this compound is being con-
sumed for resveratrol synthesis. The resveratrol synthesis 
profile coincided with that of p-coumaric acid produc-
tion, starting both at 15 h and continuing until the end of 
the experiment. During the production period that lasted 
15  h, glycerol provided carbon and energy for biomass 
production, p-coumaric acid and resveratrol synthesis. 
A final resveratrol titer of 22.58 mg/L and 9.16 mg/L of 
remaining p-coumaric acid were observed at 30 h of total 
culture time. 
These results suggest that both the production process 
and production strains can be improved. By modifying 
the inoculum ratio of both strains, it would be possible 
to couple the rate of p-coumaric acid production to its 
Fig. 5 Growth kinetics and production profiles of monocultures. 
Production of p‑coumaric acid (a) or resveratrol (b) in M9 mineral 
medium supplemented with glycerol. Error bars represent standard 
deviation
Table 5 Growth and p-coumaric acid production parameters of W(pheA−)Rg and W-Vv in glycerol M9 mineral medium, 
30 °C
a Calculated from the exponential growth phase
Strain µ (h−1) XMAX (g/L) YX/S (gDCW/gS) qS
a (gS/gDCW h)
W(pheA−)Rg 0.19 ± 0.00 0.93 ± 0.04 0.62 ± 0.34 0.37 ± 0.18
W/VvSTS 0.18 ± 0.01 1.16 ± 0.04 0.17 ± 0.02 1.12 ± 0.10
YP/S (mgP/gS) YP/X (mgp/gDCW) QP (mgp/L h) p‑CA (mg/L)
W(pheA−)Rg 4.63 ± 0.25 34.12 ± 2.91 1.10 ± 0.03 21.91 ± 0.64
Fig. 6 Growth kinetic profile of the coculture of strains W(pheA−)Rg 
and W‑Vv. Bioreactor cultures in M9 mineral medium supplemented 
with glycerol. Error bars represent standard deviation
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consumption by the resveratrol-producing strain, which 
has the potential to increase the yield of resveratrol and 
avoid the toxic effect of p-coumaric acid accumula-
tion [8]. The success of a coculture production system 
depends on the efficient exchange of molecules between 
the strains. Transport functions can be modified with the 
aim of improving the system. The aaeXAB operon in E. 
coli is involved in the excretion of various compounds, 
including p-coumaric acid [22]. It has been shown that 
overexpression of these genes results in increased toler-
ance to the toxicity of this aromatic acid [23]. Therefore, 
it can be expected that overexpression of genes aaeXAB 
in strain W(pheA-)Rg would lead to a higher secre-
tion rate for p-coumaric acid, while the inactivation 
of this operon in strain W-Vv could result in increased 
intracellular availability of this precursor for resveratrol 
synthesis.
As shown in Table  1, diverse strategies have been 
employed for the generation and cultivation of E. coli 
recombinant strains for resveratrol production. Concern-
ing strain engineering, these approaches have in common 
the heterologous expression of 4CL and STS enzymes. 
Further strain improvement modifications involve 
expressing activities that increase the supply of endog-
enous metabolic precursors for resveratrol. Cultivation 
conditions employed for resveratrol production differ 
concerning media composition. However, with the excep-
tion of the present report, p-coumaric acid or l-tyrosine 
have been supplemented as precursors and a complex 
medium was used. In the work reporting the highest level 
of resveratrol (2340  mg/L), in addition to supplementa-
tion with p-coumaric acid in a complex medium, the 
inhibitor cerulenin was employed. In contrast to these 
reports, it should be noted that the coculture system 
reported here is based on the use of a minimal medium 
where glycerol provides all the carbon atoms for resver-
atrol synthesis. As mentioned above, various strain and 
culture optimization strategies should enable to further 
increase resveratrol titer and productivity. In a recent 
report, a Saccharomyces cerevisiae strain was engineered 
for the production of resveratrol from glucose or etha-
nol. In fed-batch cultures, a maximum resveratrol titer 
of 531 mg/L was produced [24]. It remains to be deter-
mined if improvement of the E. coli coculture system can 
achieve similar results.
Conclusions
To the best of our knowledge, this is the first report on 
the use of a bacterial coculture for the synthesis of resver-
atrol. This approach opens up the possibility of harness-
ing the benefits of splitting into two strains a pathway 
that requires two different precursors belonging to dis-
tinct branches of the central metabolism. This strategy 
can also help to address some toxicity or inhibitory issues 
due to the intracellular accumulation of intermediar-
ies. Further improvements through metabolic pathway 
and bioprocess engineering could allow the independent 
optimization of partial sections of the pathway and the 
transport activities related to resveratrol synthesis with a 
potential improvement of the precursor’s supply.
Methods
Strains and plasmids
We based this work on the E. coli strain W3110, which 
is a derivative of E. coli K-12 [25]. A detailed description 
of the strains and plasmids used in this work is given in 
Table  7. Strain W(pheA−)Rg is a p-coumaric acid pro-
ducer, which was previously reported by our group [21]. 
The genes corresponding to 4CL from S. coelicolor A2 
(NP_628552.1) and STS from A. hypogaea (BAA78617.1) 
were synthesized by Life Technologies with codon opti-
mization for E. coli.
The DNA sequence of the STS gene from V. vinif-
era was synthesized by Epoch Life Science Inc. and was 
codon harmonized for improved protein expression by 
performing synonymous codon replacement of the origi-
nal sequence, with the codon having the best frequency 
match to that in the native organism. This approach was 
based on a previously published work for codon harmo-
nization [26]. Species-specific codon usage tables were 
Table 6 Growth and  production parameters for  the coculture of  strains W(pheA−)Rg and W-Vv in  glycerol M9 mineral 
medium, 30 °C
a Calculated from the exponential growth phase
µ (h−1) XMAX (g/L) YX/S (gDCW/gS) qS
a (gS/gDCW h) p‑CA
YP/S (mgP/gS) YP/X (mgp/gDCW) QP (mgp/L h) p‑CA (mg/L)
0.22 ± 0.00 1.96 ± 0.07 0.33 ± 0.10 0.72 ± 0.22 1.16 ± 0.04 5.48 ± 0.18 0.46 ± 0.00 9.16 ± 0.09
Resveratrol
YP/S (mgP/gS) YP/X (mgp/gDCW) QP (mgp/L h) Resveratrol 
(mg/L)
2.86 ± 0.36 18.86 ± 1.28 1.13 ± 0.11 22.58 ± 2.25
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obtained from the Codon Usage Database (http://www.
kazusa.or.jp/codon/), and analysis of the codon frequency 
differences was performed with the website-tool Graphi-
cal Codon Usage Analyzer available at http://www.gcua.
schoedl.de/index.html [27].
Plasmids construction
The construction of plasmids pTrc-Sc4CL-AhSTS and 
pTrc-Sc4CL-VvSTS (Table 7), were designed so that both 
genes are under the control of the Trc promoter in an 
operon with a gene encoding 4CL placed next to the pro-
moter and followed by the STS gene. The genes encod-
ing the 4CL from S. coelicolor A2 and the STS from A. 
hypogaea were placed each after a ribosome binding site 
(RBS) taken from the pTrc vector while the STS gene 
from V. vinifera (VvSTS) was designed with a customized 
RBS sequence using RBS calculator v1.1 [28].
The first construction step consisted on the individual 
cloning of the 4CL and STS synthesized genes into the 
vector pTrc99A by digestion with restriction enzymes 
NcoI/KpnI, thus generating the plasmids pTrc-sc4CL and 
pTrc-ahSTS. The gene AhSTS was then subcloned in the 
KpnI/HindIII sites of pTrc-Sc4CL, producing the plas-
mid pTrc-Sc4CL-AhSTS. Each plasmid was confirmed by 
PCR and sequencing. For the construction of the plasmid 
pTrc-Sc4CL-VvSTS, we started from pTrc-Sc4CL-AhSTS 
and replaced the sequence of the AhSTS gene with that 
of the VvSTS gene using restriction sites KpnI/HindIII.
Culture media and conditions
For plasmids construction experiments, solid and liquid 
Luria–Bertani (LB) media was used, and the antibiotics 
carbenicillin (Cb; 100  µg/mL), tetracycline (Tc; 30  µg/
mL) and kanamycin (Km; 30  µg/mL) were used when 
required for strain selection.
Cultures for the characterization  of production were 
performed in M9 mineral medium (Na2HPO4-7H2O 
12.8  g/L, KH2PO4 3  g/L, NaCl 0.5  g/L, NH4Cl 1  g/L, 
MgSO4 249  mg/L, CaCl2 11.1  mg/L, and thiamine 10 
μg/L). The carbon source was either glucose or glycerol at 
10 g/L for shake-flask experiments and the medium was 
supplemented with l-phenylalanine 0.3 mM to allow the 
growth of the pheA− mutant strain.
Culture conditions for strain characterization
Experiments for growth profile characterization were 
started with an overnight LB culture followed by an 
adaptation step carried out at a starting density of 0.1 
O.D.600 in a 250  mL baffled shake flasks with 50  mL of 
M9 medium supplemented with 10 g/L of either glucose 
or glycerol. Flasks were placed in a shaking incubator at 
30  °C and 300  rpm for 12  h. Cells were then harvested 
and used to inoculate again 250 mL baffled shake flasks 
with 50 mL of fresh M9 medium at a starting density of 
0.1 O.D.600. Cultures of strains carrying 4CL and STS 
genes were also supplemented with p-coumaric acid at a 
concentration of 3 mM. Cultures were incubated at 30 °C, 
300  rpm and induced with 0.5  mM of IPTG when they 
reached 0.8 O.D.600. Then, cultures continued for another 
20 h after induction. All cultures were performed at least 
in triplicate.
Coculture fermentations
Batch coculture fermentations were performed in 1 L 
autoclavable glass bioreactors (Applikon, The Nederlads) 
connected to an Applikon ADI 1010 BioControlleer and 
ADI1025 controllers to control pH, temperature, stir-
rer speed, and aeration rate. The working volume was 
750 mL and culture conditions were set at pH 7.0, 30 °C, 
600 rpm and an aeration rate of 0.5 vvm of sterile air. pH 
was controlled automatically by adding a solution of 10 % 
w/v NH4OH.
LB overnight cultures were used to start the inocula 
in 250 mL baffled shake flasks with 50 mL of mineral M9 
medium without addition of p-coumaric acid and supple-
mented with 0.3 mM l-phenylalanine and 10 g/L glycerol. 
Cells were then harvested to inoculate bioreactors. Cultures 
Table 7 Strains and plasmids used in this work
Strain Characteristics Reference
W3110 E. coli F−, λ−, INV (rrnD− rrnE)1 ATCC 27325
W (pheA−)Rg W3110 (pheA::Km) transformed with 
plasmid pJLBaroGfbr tktA and pTrc‑
PALRg
[21]
W‑Ah W3110 transformed with plasmid pTrc‑
Sc4CL‑AhSTS
This work




pMK‑RQ‑Sc4CL Sc4CL synthetized with optimal codon 
usage for E. coli
This work
pMA‑AhSTS AhSTS synthetized with optimal codon 
usage for E. coli
This work
pSB3K3‑VvSTS VvSTS synthetized with codon harmo‑
nization for E. coli
This work
pTrc99A Cloning vector carries bla and lacIq 
genes and trc promoter
[32]
pJLBaroGfbrtktA aroGfbr under control of the lacUV5 
promoter; and tktA under its native 
promoter, carries lacIq and tet genes
[33]
pTrcPALRg PAL gene from R. glutinis gene cloned 
in pTrc99A
[21]
pTrc‑Sc4CL‑AhSTS 4CL gene from S. coelicolor A2 (Sc) 
and STS gene from A. hypogaea (Ah) 
cloned in pTrc99A
This work
pTrc‑Sc4CL‑VvSTS 4CL gene from S. coelicolor A2 (Sc) and 
STS gene from V. vinifera (Vv) cloned 
in pTrc99A
This work
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in bioreactors were started in the same fresh medium as the 
inoculum at an O.D.600 of 0.05 for each strain, to give a final 
starting inoculum of 0.1 O.D.600. Growth was monitored, 
and when reached 0.8 O.D.600, cultures were induced at a 
final concentration of 0.5 mM of IPTG. Cultures continued 
for 20 h more after induction. Samples of 500 µL of the cul-
ture were collected for resveratrol extraction and 1 mL for 
O.D.600 and glycerol determination.
Protein expressions assays
Total protein expression was analyzed using 12 % SDS–
polyacrylamide gel electrophoresis and Coomassie blue 
staining. Briefly, 1 mL aliquots of culture were collected 
at the end of the cultures and O.D.600 was determined. All 
samples were standardized by O.D.600 (dilution to a vol-
ume of 1 mL at 3.0 O.D.600). Cells were then centrifuged, 
and the pellet resuspended in 100 µL of distilled water. 
Then 20 µL were mixed with 10 µL of loading buffer with 
β-mercaptoethanol and boiled in a water bath at 100  °C 
for 5 min. Samples of 5 µL each were loaded and resolved 
on a 12 % SDS–polyacrylamide gel, followed by Coomas-
sie blue staining.
p‑Coumaric acid and trans‑resveratrol extractions
To quantify p-coumaric acid and trans-resveratrol, 500 
µL aliquots of complete culture were mixed with an equal 
volume of ethyl acetate. The mixture was vortexed for 30 s 
and after centrifugation, 400 µL of the organic layer was 
separated in a clean microfuge tube and evaporated till 
dryness in an Eppendorf Concentrator. After that, samples 
were resolubilized in 400 µL of methanol. Finally, samples 
were filtered through Whatman Anopore inorganic filters 
of 0.2 µm before injecting into an HPLC system.
Analytical methods
Cell growth was monitored measuring optical den-
sity at 600  nm (O.D.600) in a spectrophotometer (Beck-
man DU-70; Fullerton, CA, USA). Glucose and glycerol 
concentrations were determined using an HPLC sys-
tem (600E quaternary bomb, 717 automatic injector, 
2410 refraction index, Waters, Milford, MA, USA) 
using an Aminex HPX-87H column (Bio-rad, Hercu-
les, CA, USA). 20 µL of a sample was injected using as 
mobile phase 5 mM H2SO4, with a flow rate of 0.5 mL/
min. The column temperature was set at 50  °C. Sug-
ars were detected by their refractive index. Identifica-
tion and quantitation of compounds was performed by 
comparison of each peak retention time and interpola-
tion in a standard curve. For analysis of p-coumaric acid 
and trans-resveratrol, we used an HPLC system (Agi-
lent 1100 System, Agilent Technologies, Palo Alto, CA, 
USA), with a reverse phase column (Phenomenex Syn-
ergi Hydro RP C18, 150 × 4.6 mm, 4 um, Phenomenex, 
Torrance, CA, USA) and equipped with photodiode 
array detection. We eluted the sample using an isocratic 
mobile phase of 0.1 % TFA in water (A) and 0.1 % TFA 
in methanol (B) in a ratio of 60:40 (A:B v/v). Flow was 
set at one mL/min, column temperature at 45 °C and the 
injection volume was 10 µL. Identification of p-CA and 
trans-resveratrol was performed by comparison of the 
retention times and UV/Vis spectra of each peak with 
the standards. For quantification of each component, 
calibration curves were constructed using component 
standards and by interpolation of the sample signals 
within the calibration curves.
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